Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (100.0%)Analysis of Natural Killer Cell Activity (NKA) in Whole Blood in High Risk Subjects Undergoing Colonoscopy
Not Applicable
Terminated
- Conditions
- Immunity, InnateColorectal Cancer
- First Posted Date
- 2017-08-15
- Last Posted Date
- 2023-01-31
- Lead Sponsor
- ATGen Canada Inc
- Target Recruit Count
- 396
- Registration Number
- NCT03249727
- Locations
- 🇨🇦
CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada
🇨🇦Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada
🇨🇦McGill University and the McGill University Health Centre, Montreal, Quebec, Canada
Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy
Not Applicable
Terminated
- Conditions
- Immunity, InnateProstatic Neoplasm
- First Posted Date
- 2017-08-08
- Last Posted Date
- 2019-07-05
- Lead Sponsor
- ATGen Canada Inc
- Target Recruit Count
- 84
- Registration Number
- NCT03242265
- Locations
- 🇨🇦
Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada
Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy
Not Applicable
Completed
- Conditions
- Natural Killer Cell Cytokine Production
- First Posted Date
- 2014-11-14
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- ATGen Canada Inc
- Target Recruit Count
- 1081
- Registration Number
- NCT02291198
- Locations
- 🇨🇦
Hopital Maisonneuve-Rosemont, Montreal, Quebec, Canada
News
No news found